LivaNova PLC

Financials

Total assets 2.41 B2.2 B2.29 B2.43 B2.51 B2.61 B Total liabilities 1.29 B906.31 M1.09 B1.15 B1.19 B1.41 B Total equity 1.12 B1.29 B1.21 B1.28 B1.32 B1.2 B Total liabilities & shareholders' equities 2.41 B2.2 B2.29 B2.43 B2.51 B2.61 B Total debt —————— Net debt ——————

LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".

LIVN

Financials

LivaNova PLC

ニュース

LivaNova: Excellent Performer Too Expensive In 2026 (Rating Downgrade) (NASDAQ:LIVN)

LivaNova stock hits 52-week high at $71.00

Wolfe Researchがてんかん治療の見通しを受けLivanova株の目標株価を引き上げ

Wolfe Research raises Livanova stock price target on epilepsy outlook

Stifel、Livanovaの目標株価を80ドルに引き上げ、力強い成長を評価

Stifel raises Livanova stock price target to $80 on strong growth

Needham、好調な決算を受けてLivanova株の目標株価を81ドルに引き上げ

Needham raises Livanova stock price target to $81 on strong results

LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates

LivaNova、第4四半期は力強い成長で予想を上回る

LivaNova beats fourth quarter expectations on strong growth

【決算速報】リバノバ、売上高は予想を上回り、利益は予想を上回る結果に